2-46614999-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002643.4(PIGF):āc.166C>Gā(p.Leu56Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,607,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002643.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGF | NM_002643.4 | c.166C>G | p.Leu56Val | missense_variant | 2/6 | ENST00000281382.11 | NP_002634.1 | |
PIGF | NM_173074.3 | c.166C>G | p.Leu56Val | missense_variant | 2/7 | NP_775097.1 | ||
PIGF | XM_011532908.4 | c.166C>G | p.Leu56Val | missense_variant | 2/7 | XP_011531210.1 | ||
PIGF | XM_005264369.4 | c.166C>G | p.Leu56Val | missense_variant | 2/6 | XP_005264426.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGF | ENST00000281382.11 | c.166C>G | p.Leu56Val | missense_variant | 2/6 | 1 | NM_002643.4 | ENSP00000281382 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251060Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135704
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1455612Hom.: 0 Cov.: 27 AF XY: 0.0000110 AC XY: 8AN XY: 724586
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.166C>G (p.L56V) alteration is located in exon 2 (coding exon 1) of the PIGF gene. This alteration results from a C to G substitution at nucleotide position 166, causing the leucine (L) at amino acid position 56 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at